Tirzepatide Research Overview
- Popular Name
- Dual GIP And GLP-1 Agonist
- Category
- Weight Loss & Metabolism
- Evidence Tier
- Approved Drug
- Class
- Dual GIP/GLP-1 receptor co-agonist (twincretin); synthetic 39-residue peptide with C18 fatty diacid for albumin binding
- Primary Target
- GIPR (GIP receptor) + GLP-1R (GLP-1 receptor); dual incretin axis activation; pancreatic insulin secretion and hypothalamic appetite suppression
- Half-Life
- ~1 week
- PubMed Citations
- 2,193
- Active Trials
- 174
Mechanism Of Action
It is a dual GIP and GLP-1 receptor agonist. It dramatically slows gastric emptying and sensitizes the body to insulin, resulting in profound appetite suppression and record-breaking weight loss in trials.
Studied For
Type 2 diabetes managementChronic weight management / obesityObstructive sleep apnea in obesity (FDA approved 2024)Non-alcoholic fatty liver disease (NAFLD/MASH)Cardiovascular risk reductionHbA1c loweringBody weight reduction superior to semaglutideInsulin resistance
Sourcing Tirzepatide In The Louisville Metro area
Pep Nation Lab supplies research-grade Tirzepatide to verified researchers across Prospect, KY, in Jefferson County and the wider Louisville Metro area. Every Tirzepatide order ships nationwide with full batch COA documentation, strictly for in vitro laboratory use.
- Service Area
- Prospect, KY (Louisville Metro)
- County
- Jefferson County, Kentucky
- ZIP Codes Served
- 40059
- Shipping
- Nationwide To All 50 States, Including Kentucky
- Compound
- Tirzepatide (Dual GIP And GLP-1 Agonist)
- Documentation
- Batch COA Included With Every Order
- Intended Use
- In Vitro Laboratory Research Only
Tirzepatide In Prospect - Common Questions
More Research Compounds In Prospect
BPC-157 In ProspectTB-500 In ProspectSemaglutide In ProspectRetatrutide In ProspectAll Peptides In Prospect›
Tirzepatide In Nearby Cities

